Coffee consumption has been reported to be inversely associated with hepatocellular carcinoma (HCC), the most common type of liver cancer.
READ FULL ARTICLE
From cebp.aacrjournals.org
A significant relationship has been found between coffee consumption and a reduced risk of developing hepatocellular carcinoma (HCC), but not with intrahepatic cholangiocarcinoma (ICC), according to an article published online in the journal Cancer Epidemiology, Biomarkers & Prevention.
Participants in this study included 1,212,893 participants (HCC: n = 860, ICC: n = 260) from the Liver Cancer Pooling Project.
Results showed that increased coffee consumption was associated with a reduced risk of HCC (HR > 3 cups/day vs. non-drinker, 0.73; 95% CI: 0.53, 0.99; Ptrend cups/day < 0.0001). Women who consumed more than three cups of coffee per day had a significantly more reduced risk of HCC (54%) compared to men (HR, 0.46; 95% CI: 0.26, 0.81 compared to HR, 0.93; 95% CI: 0.63, 1.37, respectively; Pinteraction = 0.07).
Caffeinated coffee (HR > 3 cups/day vs. non-drinker, 0.71; 95% CI: 0.50, 1.01) displayed a stronger association with decreased HCC risk than decaffeinated coffee (HR, 0.92; 95% CI: 0.55, 1.54).
The study suggests further evaluations be conducted on specific coffee compounds and mechanisms to better understand their association with reduced HCC risk.
Coffee consumption has been reported to be inversely associated with hepatocellular carcinoma (HCC), the most common type of liver cancer.
READ FULL ARTICLE
From cebp.aacrjournals.org
You’ve read {{metering-count}} of {{metering-total}} articles this month.
We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited content, log in or register for free.
{{login-button}} {{register-button}}
Want to view more content from Cancer Therapy Advisor?
Register now at no charge to access unlimited clinical news, full-length features, case studies, conference coverage, and more.
{{login-button}} {{register-button}}
Please login or register first to view this content.